Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2353–2376 of 6,928 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Major Depressive Disorder
Interventions: repetitive Transcranial Magnetic Stimulation; Device
Lead sponsor: Neuronetics; Other
Eligibility: 22 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Sepsis
Interventions: Bilateral phrenic nerve stimulation and measurement of transdiaphragmatic pressure, Midazolam, Volitional Measurement of Maximal Inspiratory Pressure (MIP), Inspiratory Muscle Strength Training (IMST), SHAM Inspiratory Muscle Strength Training (IMST), Diaphragm thickness measurement, Blood and Urine samples; Procedure · Drug · Device + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Parkinson Disease, Apathy
Interventions: Accelerated intermittent theta-burst stimulation (iTBS) rTMS to left dorsomedial prefrontal cortex (dmPFC); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 45 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Medullary Thyroid Cancer (MTC)
Interventions: Pembrolizumab; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Brain and Central Nervous System Tumors, Neuroblastoma
Interventions: filgrastim, carboplatin, cyclophosphamide, thiotepa, vincristine sulfate, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation, radiation therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Children's Oncology Group; Network
Eligibility: 3 Years to 21 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2007
U.S. locations: 13
States / cities: Los Angeles, California • Orange, California • Denver, Colorado + 8 more

Conditions: Extreme Prematurity
Interventions: Epo, Control; Drug · Other
Lead sponsor: University of Washington; Other
Eligibility: 24 Weeks to 27 Weeks
Enrollment: 941 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 19
States / cities: Little Rock, Arkansas • Gainesville, Florida • Miami, Florida + 14 more

Conditions: Sleep Apnea Syndromes
Interventions: Transvenous nerve stimulation; Device
Lead sponsor: Respicardia, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Winston-Salem, North Carolina • Columbus, Ohio • Bryn Mawr, Pennsylvania

Conditions: Traumatic Brain Injury
Interventions: Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel); Device
Lead sponsor: Ramon Diaz-Arrastia; Other
Eligibility: 18 Years and older
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cushing's Syndrome
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: COVID-19
Interventions: Auricular percutaneous neurostimulation; Device
Lead sponsor: Olive View-UCLA Education & Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Sylmar, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Virtual Reality; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy Volunteers, Spinal Cord Injury Cervical, Physical and Rehabilitation Medicine
Interventions: Participants will receive neuromuscular electrical stimulation via an investigational (not FDA approved) neuromuscular stimulator.; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Essential Tremor, Parkinson Disease, Dystonia
Interventions: Active biphasic pulse stimulation---Home Settings, Active biphasic pulse stimulation---VIN Biphasic, Active biphasic pulse stimulation---Stimulator Off; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Diabetic Foot Ulcer
Interventions: COMS One device, Sham device; Device
Lead sponsor: Piomic Medical; Industry
Eligibility: 22 Years to 90 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 30
States / cities: Mesa, Arizona • Tucson, Arizona • Castro Valley, California + 23 more

Conditions: Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity, Labyrinth Diseases, Vestibular Diseases, Sensation Disorders, Bilateral Vestibular Hypofunction, Bilateral Vestibulopathy, Aminoglycoside Ototoxicity
Interventions: Labyrinth Devices MVI™ Multichannel Vestibular Implant System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 22 Years to 90 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Freezing of Gait, Parkinson Disease
Interventions: OFF Parkinson's Medication(s), OFF Deep Brain Stimulation; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Depression
Interventions: Neurostimulation; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Stroke
Interventions: kTMP; Device
Lead sponsor: Magnetic Tides; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Head and Neck Cancer
Interventions: Range of Motion Therapy Program, Postural Sensory Therapy Program; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: ADHD With Working Memory Deficits
Interventions: Magstim Super Rapid2 stimulator, 10 Hz condition, Magstim Super Rapid2 stimulator, Sham condition, Magstim Super Rapid2 stimulator, iTBS condition; Device
Lead sponsor: Bradley Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: East Providence, Rhode Island

Conditions: B Cell Lymphoma, Follicular Lymphoma, Neoplasm
Interventions: Id-KLH Vaccine, QS-21 (Stimulation-QS-21) Drug; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Retinitis Pigmentosa
Interventions: Transcorneal Electrical Stimulation using Okustim device; Device
Lead sponsor: Wills Eye; Other
Eligibility: 22 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Leukemia
Interventions: filgrastim, sargramostim, cyclosporine, cytarabine, daunorubicin hydrochloride; Biological · Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 56 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 97
States / cities: Mobile, Alabama • Tucson, Arizona • Orange, California + 62 more

Conditions: Consciousness Disorders, Brain Injuries
Interventions: Low Intensity Focused Ultrasound Device; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature

Project 4A: Inspiratory Muscle Training and Diaphragm Strength

Accelerated rTMS for Apathy in Parkinson's Disease

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)

Janus Feasibility Study

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome

Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD

Evaluating Neuromuscular Stimulation for Restoring Hand Movements

Physiology, Imaging and Modeling of Essential Tremor

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

Percept Transitions in FOG and PD

Brain Stimulation and Decision-making

Amplitude Modulation Frequency Comparison in Kilohertz Transcranial Magnetic Perturbation (kTMP) for Chronic Stroke

Effects of Swallowing Therapy in Head and Neck Cancer

Brain Stimulation for Working Memory Deficits in Adolescents With ADHD

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study

S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Thalamic Low Intensity Focused Ultrasound in Brain Injury